These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16737834)

  • 1. The frequent observation of evidence for nonsense-mediated decay in RNA from patients with carbamyl phosphate synthetase I deficiency.
    Eeds AM; Hall LD; Yadav M; Willis A; Summar S; Putnam A; Barr F; Summar ML
    Mol Genet Metab; 2006; 89(1-2):80-6. PubMed ID: 16737834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the muscle glycogen phosphorylase gene in patients with McArdle disease: the role of nonsense-mediated mRNA decay.
    Nogales-Gadea G; Rubio JC; Fernandez-Cadenas I; Garcia-Consuegra I; Lucia A; Cabello A; Garcia-Arumi E; Arenas J; Andreu AL; Martín MA
    Hum Mutat; 2008 Feb; 29(2):277-83. PubMed ID: 17994553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of nonsense-mediated mRNA decay in mutant alleles identified in Spanish Gaucher disease patients.
    Montfort M; Chabás A; Vilageliu L; Grinberg D
    Blood Cells Mol Dis; 2006; 36(1):46-52. PubMed ID: 16326120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding carbamoyl phosphate synthetase deficiency: impact of clinical mutations on enzyme functionality.
    Yefimenko I; Fresquet V; Marco-Marín C; Rubio V; Cervera J
    J Mol Biol; 2005 May; 349(1):127-41. PubMed ID: 15876373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel PYGM mutation in a Korean patient with McArdle disease: the role of nonsense-mediated mRNA decay.
    Sohn EH; Kim HS; Lee AY; Fukuda T; Sugie H; Kim DS
    Neuromuscul Disord; 2008 Nov; 18(11):886-9. PubMed ID: 18667317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges.
    Kuzmiak HA; Maquat LE
    Trends Mol Med; 2006 Jul; 12(7):306-16. PubMed ID: 16782405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmentally determined genetic expression: clinical correlates with molecular variants of carbamyl phosphate synthetase I.
    Summar ML; Hall L; Christman B; Barr F; Smith H; Kallianpur A; Brown N; Yadav M; Willis A; Eeds A; Cermak E; Summar S; Wilson A; Arvin M; Putnam A; Wills M; Cunningham G
    Mol Genet Metab; 2004 Apr; 81 Suppl 1():S12-9. PubMed ID: 15050969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbamoyl phosphate synthetase 1 deficiency in Italy: clinical and genetic findings in a heterogeneous cohort.
    Funghini S; Thusberg J; Spada M; Gasperini S; Parini R; Ventura L; Meli C; De Cosmo L; Sibilio M; Mooney SD; Guerrini R; Donati MA; Morrone A
    Gene; 2012 Feb; 493(2):228-34. PubMed ID: 22173106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of novel NF1 mutations and rapid mutation prescreening with Pyrosequencing.
    Brinckmann A; Mischung C; Bässmann I; Kühnisch J; Schuelke M; Tinschert S; Nürnberg P
    Electrophoresis; 2007 Dec; 28(23):4295-301. PubMed ID: 18041031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mammalian nonsense-mediated mRNA decay pathway: to decay or not to decay! Which players make the decision?
    Silva AL; Romão L
    FEBS Lett; 2009 Feb; 583(3):499-505. PubMed ID: 19162024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nonsense mutation is responsible for the RNA-negative phenotype in human citrullinaemia.
    Li CM; Chao HK; Liu YF; Su TS
    Eur J Hum Genet; 2001 Sep; 9(9):685-9. PubMed ID: 11571557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of twelve natural PROS1 mutations associated with anticoagulant protein S deficiency.
    Hurtado B; Muñoz X; Mulero MC; Navarro G; Domènech P; García de Frutos P; Pérez-Riba M; Sala N
    Haematologica; 2008 Apr; 93(4):574-80. PubMed ID: 18322254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural organization of the human carbamyl phosphate synthetase I gene (CPS1) and identification of two novel genetic lesions.
    Funghini S; Donati MA; Pasquini E; Zammarchi E; Morrone A
    Hum Mutat; 2003 Oct; 22(4):340-1. PubMed ID: 12955727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DHCR7 nonsense mutations and characterisation of mRNA nonsense mediated decay in Smith-Lemli-Opitz syndrome.
    Correa-Cerro LS; Wassif CA; Waye JS; Krakowiak PA; Cozma D; Dobson NR; Levin SW; Anadiotis G; Steiner RD; Krajewska-Walasek M; Nowaczyk MJ; Porter FD
    J Med Genet; 2005 Apr; 42(4):350-7. PubMed ID: 15805162
    [No Abstract]   [Full Text] [Related]  

  • 16. NF1 mutation rather than individual genetic variability is the main determinant of the NF1-transcriptional profile of mutations affecting splicing.
    Pros E; Larriba S; López E; Ravella A; Gili ML; Kruyer H; Valls J; Serra E; Lázaro C
    Hum Mutat; 2006 Nov; 27(11):1104-14. PubMed ID: 16937374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting the molecular mechanisms in craniofrontonasal syndrome: differential mRNA expression of mutant EFNB1 and the cellular mosaic.
    Wieland I; Makarov R; Reardon W; Tinschert S; Goldenberg A; Thierry P; Wieacker P
    Eur J Hum Genet; 2008 Feb; 16(2):184-91. PubMed ID: 18043713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of three novel splicing mutations causing factor V deficiency and analysis of the F5 gene splicing pattern.
    Dall'Osso C; Guella I; Duga S; Locatelli N; Paraboschi EM; Spreafico M; Afrasiabi A; Pechlaner C; Peyvandi F; Tenchini ML; Asselta R
    Haematologica; 2008 Oct; 93(10):1505-13. PubMed ID: 18728029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GALNS gene expression profiling in Morquio A patients' fibroblasts.
    Carraresi L; Parini R; Filoni C; Caciotti A; Sersale G; Tomatsu S; Orlando C; Zammarchi E; Guerrini R; Donati MA; Morrone A
    Clin Chim Acta; 2008 Nov; 397(1-2):72-6. PubMed ID: 18710657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Execution of nonsense-mediated mRNA decay: what defines a substrate?
    Rebbapragada I; Lykke-Andersen J
    Curr Opin Cell Biol; 2009 Jun; 21(3):394-402. PubMed ID: 19359157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.